Supplementary Figures S1, S2 and S3 from Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells — Pol Giménez‐Xavier (2023) | RDL Network
Supplementary Figures S1, S2 and S3 from Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells
Preprint 2023 en
Authors
PG
Pol Giménez‐Xavier
EP
Eva Pros
EB
Ester Bonastre
Abstract
1 min read
<p>Supplementary Figure S1. Cell viability and colony formation assays of the indicated cell lines. Supplementary Figure S2. Multidimensional scaling plots Supplementary Figure S3. Cell viability assays and western blots</p>
Pol Giménez‐Xavier, Eva Pros, Ester Bonastre, Sebastián Morán, Ana Aza, Osvaldo Graña‐Castro, Gonzalo Goméz-López, Sophia Derdak, Marc Dabad, Anna Esteve‐Codina, José Ramón Hernández Mora, Diana Salinas-Chaparro, Manel Esteller, David G. Pisano, Montse Sánchez‐Céspedes
Pol Giménez‐Xavier, Eva Pros, Ester Bonastre, Sebastián Morán, Ana Aza, Osvaldo Graña‐Castro, Gonzalo Goméz-López, Sophia Derdak, Marc Dabad, Anna Esteve‐Codina, José Ramón Hernández Mora, Diana Salinas-Chaparro, Manel Esteller, David G. Pisano, Montse Sánchez‐Céspedes
Pol Giménez‐Xavier, Eva Pros, Ester Bonastre, Sebastián Morán, Ana Aza, Osvaldo Graña‐Castro, Gonzalo Goméz-López, Sophia Derdak, Marc Dabad, Anna Esteve‐Codina, José Ramón Hernández Mora, Diana Salinas-Chaparro, Manel Esteller, David G. Pisano, Montse Sánchez‐Céspedes
Pol Giménez‐Xavier, Eva Pros, Ester Bonastre, Sebastián Morán, Ana Aza, Osvaldo Graña‐Castro, Gonzalo Goméz-López, Sophia Derdak, Marc Dabad, Anna Esteve‐Codina, José Ramón Hernández Mora, Diana Salinas-Chaparro, Manel Esteller, David G. Pisano, Montse Sánchez‐Céspedes
Pol Giménez‐Xavier, Eva Pros, Ester Bonastre, Sebastián Morán, Ana Aza, Osvaldo Graña‐Castro, Gonzalo Goméz-López, Sophia Derdak, Marc Dabad, Anna Esteve‐Codina, José Ramón Hernández Mora, Diana Salinas-Chaparro, Manel Esteller, David G. Pisano, Montse Sánchez‐Céspedes
Discussion(0)
No comments yet. Be the first to comment.